These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 35760347)
1. Should anti-malarial chemoprophylaxis be reimbursed in France? A cost-effectiveness analysis of different reimbursement strategies. Fiorina C; Josselin JM; Trépart-Normand M; Tattevin P; Bajeux E Infect Dis Now; 2022 Sep; 52(6):349-357. PubMed ID: 35760347 [TBL] [Abstract][Full Text] [Related]
2. Barriers to malaria prevention among immigrant travelers in the United States who visit friends and relatives in sub-Saharan Africa: A cross-sectional, multi-setting survey of knowledge, attitudes, and practices. Volkman HR; Walz EJ; Wanduragala D; Schiffman E; Frosch A; Alpern JD; Walker PF; Angelo KM; Coyle C; Mohamud MA; Mwangi E; Haizel-Cobbina J; Nchanji C; Johnson RS; Ladze B; Dunlop SJ; Stauffer WM PLoS One; 2020; 15(3):e0229565. PubMed ID: 32163426 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa. Widmer LL; Blank PR; Van Herck K; Hatz C; Schlagenhauf P BMC Infect Dis; 2010 Sep; 10():279. PubMed ID: 20860809 [TBL] [Abstract][Full Text] [Related]
4. Reimbursement of malaria chemoprophylaxis for travellers from Europe to Sub-Saharan Africa: Cost-effectiveness analysis from the perspective of the French national health insurance system. Pistone T; Schwarzinger M; Chauvin P; Ezzedine K; Receveur MC; Djossou F; Siriwardana M; Larouzé B; Malvy D Health Policy; 2008 Dec; 88(2-3):186-99. PubMed ID: 18440663 [TBL] [Abstract][Full Text] [Related]
13. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain. Tunis SL; Willis WD; Foos V Curr Med Res Opin; 2010 Jan; 26(1):163-75. PubMed ID: 19919377 [TBL] [Abstract][Full Text] [Related]
14. New guidelines for the prevention of imported malaria in France. Delaigue S; Signolet I; Consigny PH; de Gentile L; D'Ortenzio E; Gautret P; Sorge F; Strady C; Bouchaud O Med Mal Infect; 2020 Mar; 50(2):113-126. PubMed ID: 31472994 [TBL] [Abstract][Full Text] [Related]
15. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I Encephale; 2005; 31(2):235-46. PubMed ID: 15959450 [TBL] [Abstract][Full Text] [Related]
16. Antimosquito precautions and medical chemoprophylaxis in French children with malaria. Minodier P; Kone-Paut I; Nassur A; Launay F; Jouve JL; Hassid S; Retornaz K; Garnier JM J Travel Med; 2003; 10(6):318-23. PubMed ID: 14642197 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of malaria control in sub-Saharan Africa. Goodman CA; Coleman PG; Mills AJ Lancet; 1999 Jul; 354(9176):378-85. PubMed ID: 10437867 [TBL] [Abstract][Full Text] [Related]
18. Trend analysis of imported malaria in London; observational study 2000 to 2014. Rees E; Saavedra-Campos M; Usdin M; Anderson C; Freedman J; de Burgh J; Kirkbride H; Chiodini P; Smith V; Blaze M; Whitty CJM; Balasegaram S Travel Med Infect Dis; 2017; 17():35-42. PubMed ID: 28456684 [TBL] [Abstract][Full Text] [Related]
19. Pretravel health preparation among US residents traveling to India to VFRs: importance of ethnicity in defining VFRs. Baggett HC; Graham S; Kozarsky PE; Gallagher N; Blumensaadt S; Bateman J; Edelson PJ; Arguin PM; Steele S; Russell M; Reed C J Travel Med; 2009; 16(2):112-8. PubMed ID: 19335811 [TBL] [Abstract][Full Text] [Related]
20. Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries. Massad E; Behrens BC; Coutinho FA; Behrens RH Malar J; 2011 May; 10():130. PubMed ID: 21586155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]